Format
Items per page
Sort by

Send to:

Choose Destination

Results: 10

1.

mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer.

von der Heyde S, Wagner S, Czerny A, Nietert M, Ludewig F, Salinas-Riester G, Arlt D, Beißbarth T.

PLoS One. 2015 Feb 24;10(2):e0117818. doi: 10.1371/journal.pone.0117818. eCollection 2015.

2.

Human migratory meniscus progenitor cells are controlled via the TGF-β pathway.

Muhammad H, Schminke B, Bode C, Roth M, Albert J, von der Heyde S, Rosen V, Miosge N.

Stem Cell Reports. 2014 Nov 11;3(5):789-803. doi: 10.1016/j.stemcr.2014.08.010. Epub 2014 Sep 25.

3.

RPPanalyzer toolbox: an improved R package for analysis of reverse phase protein array data.

von der Heyde S, Sonntag J, Kaschek D, Bender C, Bues J, Wachter A, Timmer J, Korf U, Beißbarth T.

Biotechniques. 2014 Sep 1;57(3):125-35. doi: 10.2144/000114205. eCollection 2014.

4.

Boolean ErbB network reconstructions and perturbation simulations reveal individual drug response in different breast cancer cell lines.

von der Heyde S, Bender C, Henjes F, Sonntag J, Korf U, Beißbarth T.

BMC Syst Biol. 2014 Jun 25;8:75. doi: 10.1186/1752-0509-8-75.

5.

Dynamics of mRNA and polysomal abundance in early 3T3-L1 adipogenesis.

von der Heyde S, Fromm-Dornieden C, Salinas-Riester G, Beissbarth T, Baumgartner BG.

BMC Genomics. 2014 May 18;15:381. doi: 10.1186/1471-2164-15-381.

6.

Extrinsic and intrinsic regulation of DOR/TP53INP2 expression in mice: effects of dietary fat content, tissue type and sex in adipose and muscle tissues.

Fromm-Dornieden C, Lytovchenko O, von der Heyde S, Behnke N, Hogl S, Berghoff J, Köpper F, Opitz L, Renne U, Hoeflich A, Beissbarth T, Brenig B, Baumgartner BG.

Nutr Metab (Lond). 2012 Sep 21;9(1):86. doi: 10.1186/1743-7075-9-86.

8.

Novel polysome messages and changes in translational activity appear after induction of adipogenesis in 3T3-L1 cells.

Fromm-Dornieden C, von der Heyde S, Lytovchenko O, Salinas-Riester G, Brenig B, Beissbarth T, Baumgartner BG.

BMC Mol Biol. 2012 Mar 21;13:9. doi: 10.1186/1471-2199-13-9.

9.

Strong EGFR signaling in cell line models of ERBB2-amplified breast cancer attenuates response towards ERBB2-targeting drugs.

Henjes F, Bender C, von der Heyde S, Braun L, Mannsperger HA, Schmidt C, Wiemann S, Hasmann M, Aulmann S, Beissbarth T, Korf U.

Oncogenesis. 2012 Jul 2;1:e16. doi: 10.1038/oncsis.2012.16.

10.

Stress regulation and self-mutilation.

Sachsse U, Von der Heyde S, Huether G.

Am J Psychiatry. 2002 Apr;159(4):672. No abstract available.

PMID:
11925313
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk